Sanofi treatment could slow type 1 diabetes progression
New Sanofi Phase III trial data adds to evidence of the treatment potential for the first disease modifying therapy in type 1 diabetes.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
